Inanovate
Latest round
- Series C
Last raised
- Apr 2019
Total raised
- $3.1M
Investors
- 2
About Inanovate
Inanovate, Inc. is a biotechnology company focused on transforming diagnostic testing through innovative technology.Founded in 2006 in Sioux Falls, US, Inanovate, Inc. specializes in diagnostic solutions.440 mn.Inanovate's core product offering is the Bio-ID, a compact, bench-top analyzer designed to revolutionize diagnostic testing by enabling the rapid and precise measurement of multiple disease-related biomarkers from patient blood samples. Utilizing a proprietary technology known as Longitudinal Assay Screening (LAS), developed in 2010, the Bio-ID allows end-users to load test samples into disposable cartridges, insert them into the analyzer, and initiate a test with the push of a button. This innovative platform serves both research and clinical markets, aiming to improve diagnostic accuracy and reduce costs associated with traditional testing methods.Inanovate generates revenue primarily through the sale of its flagship product, the Bio-ID, alongside associated services such as support and maintenance for the analyzer system. The transaction structure typically involves direct sales to healthcare providers, research institutions, and diagnostic companies, emphasizing a B2B model. Clients purchase the Bio-ID analyzer and its disposable test cartridges, with potential for ongoing revenue through service contracts and consumable sales. The company is focusing on enhancing its Bio-ID platform and aims to introduce additional diagnostic capabilities by 2023. Moreover, Inanovate is targeting expansion into European and Asia-Pacific markets to increase its global footprint and meet the rising demand for advanced diagnostic solutions.
Who invested in Inanovate
2 investors across 1 round
See all investors in Inanovate
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Apr 3, 2019
Amount
$3.1M
Investors
Questions about Inanovate
Who invested in Inanovate?
Inanovate has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inanovate raised?
Inanovate has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inanovate last raise money?
Inanovate's most recent round on record is a Series C, in Apr 2019.
What does Inanovate do?
Inanovate is a biotechnology company.
Where is Inanovate headquartered?
Inanovate is headquartered in Sioux Falls, US.
Which VCs invest in companies like Inanovate?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inanovate's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Inanovate? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.